Secondary Schools

School of Pharmaceutical Science and Technology

党健鹏

Sponsor:Shanghai Institute of Materia Medica, CAS

Dean:Jiang Hualiang,academician

Executive dean:Huang Wei

Academician list: Ding Jian, Jiang Hualiang

The school construction goal is based on the principle of “adhering to first-class standards, combining major needs, meeting national plans, strengthening dynamic monitoring and strengthening performance-related incentives”. The school will be built into a new drug development institution and pharmaceutical personnel training base, with “special features, interdisciplinary type, high level and internationalization”.

School of Pharmaceutical Science and Technology

Research Center for Medicinal Chemistry

Research Center for Chemical Biology

Research Center for Tumor Pharmacology

Research Center for Metabolism and Immunopharmacology

Prof. Liu Hong workshop

Prof. Hu Youhong workshop

Prof. Zhou Bing workshop

Prof. Jiang Hualiang workshop

Prof. Yang Caiguang workshop

Prof. Huang Wei workshop

Prof. Ding Jian workshop

Prof. Geng Meiyu workshop

Prof. Luo Cheng workshop

Prof. Li Jia workshop

Prof. Xie Xin workshop

Prof. Wu Beili workshop

The Research Center for Medicinal Chemistry covers three research fields: small molecule drug and probe discovery, high efficiency synthesis and drug discovery, structure optimization and pharmaceutical study. The Research Center for Chemical Biology covers three research fields: computational chemistry and biology, protein chemical biology and glyco-chemistry biology; The Research Center for Tumor Pharmacology includes three research fields: anti-tumor drug discovery, tumor drug resistance and biomarkers, and anti-tumor drug target.The Research Center for Metabolism and Immunopharmacology covers three research fields of metabolic pharmacology, immunopharmacology, receptor structure and function.

Three major directions for breakthrough

Focus on key technologies for drug design based on big data and artificial intelligence

Discovery and validation for novel drug targets of source innovation

Research and development of new drugs and new therapeutic strategies for tumor, metabolic and immune diseases

Five key development directions

Study on small molecule drugs based on protein-protein interaction

New drug research and development strategy based on bio glycopeptide microchip technology

Disease treatment scheme based on regulation mechanism for intestinal microbiota

Study on mechanism of tumor drug resistance based on multi-system interaction regulation

Cell/gene therapy based on tumor, immune or metabolic diseases

Address

No. 1, Xiangshan Zhinong, Xihu District, Hangzhou

310024

Wechat official account

Copyright © University of Chinese Academy of Sciences, all rights reserved, record No.: Jing ICP Bei No. 07017956